Table 3 Results of multiple linear regression model for associations with post-transplantation phosphate nadir
From: Clinical factors associated with severe hypophosphataemia after kidney transplant
Variable | Exponentiated regression coefficient estimate | P-value | Relative Importance |
|---|---|---|---|
Epidemiological | |||
 Recipient sex (male) | 1.01 | 0.601 | 0.19% |
 Age at transplantation (per 10 years) | 1.00 | 0.864 | 1.66% |
 Donor sex (male) | 1.00 | 0.883 | 0.08% |
 Donor age (per 10 years) | 1.03 | <0.001 | 9.6% |
 Transplant type (live) | 0.89 | <0.001 | 14.66% |
Biochemical | |||
 Mean pre-transplantation phosphate (mmol/L) | 0.94 | 0.001 | 4.79% |
 Mean pre-transplantation adjusted calcium (mmol/L) | 0.75 | <0.001 | 10.77% |
 Mean pre-transplantation alkaline phosphatase (per 10 U/L) | 1.00 | 0.127 | 3.34% |
 Mean pre-transplantation PTH (per multiple of upper limit of normal) | 1.00 | 0.243 | 0.47% |
Clinical | |||
 Duration of RRT pre-transplantation (years) | 1.00 | 0.498 | 1.02% |
 Parathyroidectomy pre-transplantation | 1.21 | <0.001 | 22.48% |
 On alfacalcidol or calcitriol pre-transplantation | 0.97 | 0.077 | 0.62% |
 Era of immunosuppression (post-01/01/2007) | 0.95 | 0.052 | 4.92% |
 Delayed graft function | 1.16 | <0.001 | 25.41% |